Can functional magnetic resonance imaging improve success rates in central nervous system drug discovery?

Author： Borsook David   Hargreaves Richard J   Becerra Lino  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.6, 2011-06, pp. : 597-617

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood-brain Barrier Drug Discovery for Central Nervous System Infections

By  

Current Drug Targets - Infectious Disorders, Vol. 5, Iss. 1, 2005-03 ,pp. : 65-72

Bentham Science Publishers

Access to resources Recommend Favorite

Magnetic resonance imaging in drug discovery: lessons from disease areas

By Beckmann N.   Laurent D.   Tigani B.   Panizzutti R.   Rudin M.  

Drug Discovery Today, Vol. 9, Iss. 1, 2004-01 ,pp. : 35-42

Elsevier

Access to resources Recommend Favorite

Imaging of Muscarinic Receptors in the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 12, Iss. 30, 2006-10 ,pp. : 3901-3913

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HIV Drug Distribution to the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1313-1324

Bentham Science Publishers

Access to resources Recommend Favorite

Current Approaches for Drug Delivery to Central Nervous System

By  

Current Drug Delivery, Vol. 7, Iss. 5, 2010-12 ,pp. : 389-397

Bentham Science Publishers

Access to resources Recommend Favorite